Results 171 to 180 of about 14,363 (250)

Evidence on Indications and Techniques to Increase the Future Liver Remnant in Children Undergoing Extended Hepatectomy: A Systematic Review and Meta-Analysis of Individual Patient Data. [PDF]

Front Pediatr, 2022
Fuchs J, Murtha-Lemekhova A, Rabaux-Eygasier L, Kessler M, Ruping F, Günther P, Hoffmann K.   +6 more
europepmc   +1 more source

Baseline Regional Cholinergic Denervation Predicts Cognitive Trajectories in Moderate Parkinson Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Cognitive decline is a disabling and variable feature of Parkinson disease (PD). While cholinergic system degeneration is linked to cognitive impairments in PD, most prior research reported cross‐sectional associations. We aimed to fill this gap by investigating whether baseline regional cerebral vesicular acetylcholine transporter ...
Taylor Brown, Giulia Carli, Prabesh Kanel, Stiven Roytman, Jaimie Barr, Nicolaas I. Bohnen, Roger L. Albin   +6 more
wiley   +1 more source

Correlation between intrahepatic iodine quantity after portal vein embolization and future liver remnant hypertrophy. [PDF]

Jpn J Radiol
Komada T, Sato Y, Matsushima M, Uemura T, Tamashiro D, Asai R, Ito K, Mizuno T, Ebata T, Naganawa S.   +9 more
europepmc   +1 more source

Additional partial hepatectomy at the time of portal vein ligation accelerates the regeneration of the future liver remnant. [PDF]

Sci Rep, 2021
Hua C, Wei W, Zhang T, Xu F, Dirsch O, Homeyer A, Settmacher U, Dahmen U.   +7 more
europepmc   +1 more source

A Systematic Review and Meta‐Analysis of the Recurrence of Autoimmune Encephalitis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Autoimmune encephalitis (AE) is a disease with a potential for recurrence, and patients receive immunotherapy to prevent it. However, there is no consensus on the duration of immunotherapy. This study aimed to determine the recurrence rate and identify the risk factors for AE to provide guidance on the duration of immunotherapy ...
Shangkai Bai, Sen Zhang, Haipei Zhang, Yating Zhang, Junhong Guo, Xiaoyan Yang   +5 more
wiley   +1 more source

A Multiphase CT-Based Radiomics-Clinical Model to Identify Inadequate Future Liver Remnant Hypertrophy After Portal Vein Embolization Before Major Hepatectomy. [PDF]

Cancer Manag Res
Zhou R, Liu D, Huang J, Liu F, Zhou W, Zou M, Wu X, Liu H, Jia N.   +8 more
europepmc   +1 more source

Impact of sarcopenia on the future liver remnant growth after portal vein embolization and associating liver partition and portal vein ligation for staged hepatectomy in patients with liver cancer: A systematic review. [PDF]

Front Oncol, 2022
Wang Q, Wang A, Li Z, Sparrelid E, Brismar TB.   +4 more
europepmc   +1 more source

Location‐Specific Hematoma Volume Predicts Early Neurological Deterioration in Supratentorial ICH

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Early neurological deterioration (END) adversely affects outcomes in patients with intracerebral hemorrhage (ICH). This study aimed to determine the location‐specific hematoma volumes for END in supratentorial ICH patients. Methods We retrospectively analyzed supratentorial ICH patients presenting from two prospective cohorts.
Zuoqiao Li, Guilin Meng, Zijie Wang, Xiao Hu, Jing Cheng, Chu Chen, Tiannan Yang, Jiaxin Luo, Zizhen Meng, Xueyun Liu, Qi Li   +10 more
wiley   +1 more source

Augmenting the Future Liver Remnant Prior to Major Hepatectomy: A Review of Options on the Menu. [PDF]

Ann Surg Oncol
Wong P, Vien P, Kessler J, Lafaro K, Wei A, Melstrom LG.   +5 more
europepmc   +1 more source

Portal vein embolization via the ipsilateral percutaneous transhepatic approach versus laparotomic transileocecal approach: complications, profile and changes in future liver remnant volume. [PDF]

Br J Radiol, 2022
Okada M, Ihara K, Miyoshi K, Nakao S, Tanabe M, Tokumitsu Y, Harada E, Sakamoto K, Nagano H, Ito K.   +9 more
europepmc   +1 more source